Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
When it comes to predicting an individual’s risk of suffering a heart attack or stroke over the next 10 years, machine learning models are no more consistent than traditional statistical techniques.
Leaders of the venture, dubbed “Project Amber,” are open-sourcing their technology and findings in the hope that other mental health researchers can take things from here.
A little more than a year after inking a 10-year pact on digital healthcare development, Mayo Clinic and Google Health have launched their first major research project together. Interestingly, it directly involves AI.
The three states of Southern New England will be looking for a threepeat of sorts this year, as they placed first, second and third for the 2019-20 season.
The bytes are accumulating far too fast for any human effort to connect whatever dots might be hiding in the massive muddle. Enter 40 researchers at 11 sites armed with AI and almost $18 million in new NIH funding.
Analyzing the scientific literature on medical AI published over the past 46 years, researchers in the U.K. have found the U.S. far ahead of the field for sheer quantity.
Google Health all but invited the blowback when its AI developer-researchers suggested their breast-cancer model may be superior to radiologists’ eyes and generalizable across differing demographics.
